DAX22.567 +0,6%ESt505.176 +0,3%Top 10 Crypto12,43 +2,4%Dow40.528 +0,8%Nas17.461 +0,6%Bitcoin83.624 +1,0%Euro1,1379 -0,1%Öl63,62 -0,7%Gold3.281 -1,1%

1 Aktie gratis Trading Krypto kaufen^* ETF-Sparplan

Stabile Performance trotz Börsenturbulenzen: Sichere dir spannende Trades mit unserem neuen Bulle & Bär-Depot! - Jetzt Depot entdecken

Pharma Equity Group A-S Registered Aktie

NeuKaufen Verkaufen

0,0799 DKK -0,0046 DKK -5,44 %

29.04.2025

CPH

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Bei einem anderen Broker handeln Smartphone

Smartphone

Marktkap.13,14 Mio. EUR

Div. Rendite0,00%

WKNA2PUQT

ISINDK0061155009

Werbung

Pharma Equity Group A-S Registered Aktien News

Sortieren:Datum Meistgelesen

01.04.25GlobeNewswireThe Board of Directors' resolution on the issuance of convertible loans

25.03.25GlobeNewswireNotice convening the annual general meeting in Pharma Equity Group A/S

20.03.25GlobeNewswirePharma Equity Group A/S - Annual Report 2024

28.02.25GlobeNewswire2025 Financial Calendar

28.02.25GlobeNewswireChange of executive management and organizational change in Pharma Equity Group A/S

14.01.25GlobeNewswirePharma Equity Group 2025 Financial Calendar

13.12.24GlobeNewswireThe Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

29.11.24GlobeNewswireMartin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

15.11.24GlobeNewswireConsolidated Interim report 1 January – 30 September 2024

23.10.24GlobeNewswirePharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

14.10.24GlobeNewswireMajor shareholder announcement - Pharma Equity Group A/S

14.10.24GlobeNewswireManagers’ transactions

11.10.24GlobeNewswirePharma Equity Group announces successful completion of directed issue of new shares

04.10.24GlobeNewswirePharma Equity Group announces issuance of new shares in a direct issue

04.10.24GlobeNewswireRegistration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights

16.08.24GlobeNewswireConsolidated Interim Report 1 January – 30 June 2024

16.07.24GlobeNewswireThe Board of Directors' decision to issue convertible loans

15.07.24GlobeNewswireMajor shareholder announcement - Pharma Equity Group A/S

15.07.24GlobeNewswireMajor shareholder announcement - Pharma Equity Group A/S

03.06.24GlobeNewswireResults of extraordinary general meeting in Pharma Equity Group A/S

16.05.24GlobeNewswireThe Board of Director's decision to issue convertible loans

16.05.24GlobeNewswireConsolidated interim report 1 January – 31 March 2024

08.05.24GlobeNewswireExploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S

08.05.24GlobeNewswireNotice convening the extraordinary general meeting of Pharma Equity Group A/S

23.04.24GlobeNewswireMajor shareholder announcement - Pharma Equity Group A/S

16.04.24GlobeNewswirePassing of the General Meeting of Pharma Equity Group A/S

10.04.24GlobeNewswireThe Board of Director's decision to issue convertible loans

05.04.24GlobeNewswirePharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051.

25.03.24GlobeNewswireNotice convening the annual general meeting in Pharma Equity Group A/S

22.03.24GlobeNewswirePharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009

21.03.24GlobeNewswireCompletion of subscription of convertible loans

20.03.24GlobeNewswirePharma Equity Group A/S - Annual Report 2023

05.03.24GlobeNewswirePharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for pr

07.02.24GlobeNewswireCompletion of subscription of convertible loans

07.02.24GlobeNewswireThe Board of Director's decision to issue convertible loans

25.01.24GlobeNewswireCompletion of subscription of convertible loans

22.01.24GlobeNewswireNotification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions aiming to eliminate bacterial promoters of colorectal cancer through intraluminal

22.01.24GlobeNewswireThe Board of Director's decision to issue convertible loans

28.11.23GlobeNewswireStatus of the Company's receivable from Portinho S.A.

28.11.23GlobeNewswire2024 Financial Calendar

Werbung

Pharma Equity Group A-S Registered News

Pharma Equity Group A-S Registered News: auf dieser Seite finden Sie alle Pharma Equity Group A-S Registered News und Nachrichten zur Pharma Equity Group A-S Registered Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pharma Equity Group A-S Registered News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pharma Equity Group A-S Registered News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.